Business Segments · Total revenues
North American Pharmaceutical — Total revenues
McKesson North American Pharmaceutical — Total revenues increased by 2.1% to $88.32B in Q4 2025 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ3 2024
Last reportedQ4 2025
Rolls up toTotal Revenue
How to read this metric
Higher revenue indicates strong market demand, successful contract wins, or favorable pricing trends in the pharmaceutical supply chain.
Detailed definition
This metric represents the total gross sales generated by the North American Pharmaceutical segment from the distributio...
Peer comparison
The primary benchmark for scale among pharmaceutical wholesalers, directly comparable to revenue segments at Cencora and Cardinal Health.
Metric ID:
mck_segment_north_american_pharmaceutical_total_revenuesHistorical Data
4 periods
| Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|
| Value | $80.02B | $81.20B | $86.48B | $88.32B |
| QoQ Change | — | +1.5% | +6.5% | +2.1% |
| YoY Change | — | — | +8.1% | +8.8% |
Range$80.02B – $88.32B
Avg YoY Growth+8.4%
Median YoY Growth+8.4%
Current Streak3+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's north american pharmaceutical — total revenues?
- McKesson (MCK) reported north american pharmaceutical — total revenues of $88.32B in Q4 2025.
- What does north american pharmaceutical — total revenues mean?
- The total sales revenue generated by the North American Pharmaceutical segment.